The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation

NCT05262608 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate Carcinoma
Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Olaparib

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]